GeneDx Holdings Corp.
Nasdaq · Services-Health Services
Company Overview
A concise company profile alongside the latest public filing activity.
GeneDx Holdings Corp. provides genetic and genomic testing services, including exome and genome sequencing, aimed at helping diagnose rare and undiagnosed diseases in children and adults. It works with clinicians and health systems to interpret genetic data and support diagnosis and treatment decisions.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Feeley KevinCHIEF FINANCIAL OFFICER | Sell | $144K | 1,470at $98.27 | Sep 16, 2026 |
| Feeley KevinCHIEF FINANCIAL OFFICER | Sell | $107K | 1,079at $99.00 | Sep 16, 2026 |
| Feeley KevinCHIEF FINANCIAL OFFICER | Sell | $55K | 586at $94.26 | Sep 16, 2026 |
| Feeley KevinCHIEF FINANCIAL OFFICER | Sell | $52K | 541at $96.90 | Sep 16, 2026 |
| Feeley KevinCHIEF FINANCIAL OFFICER | Sell | $5K | 52at $95.41 | Sep 16, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable WGS activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.